DermaPlus designs and manufactures sophisticated, high performance anti-aging skincare products that incorporate tissue regenerating applications of its proprietary DNA plant technology, Elastatropin which is based on human genetic sequences. Sophisticated, custom designed and manufactured biopolymers such as those developed by DermaPlus are not currently in other skin care products.
DermaPlus Inc. was formed to benefit from patents and related technology developed by Dr. Burt Ensley. Dr. Ensley's technology and know-how result from rapid progress in the fields of genomics. His discoveries regarding wound healing for soldiers led him to utilize this same technology in entirely unique skin care products with enhanced performance.
Cutting edge clinical trials support the effectiveness of Elastatropin as a vehicle to safe and healthy skin rejuvenation.
